Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters

International Journal of Nursing Studies

Volumn 124, Issue , 2021, Pages

  Marsh, Nicole ^a,b,c,f,i   Larsen, Emily N ^a,b,c,e,h   Takashima, Mari ^a,c,e,h,i   Kleidon, Tricia ^a,b,c,e,f   Keogh, Samantha ^a,b,f   Ullman, Amanda J ^a,b,c,e,i   Mihala, Gabor ^a,d,e,h   Chopra, Vineet ^a,g   Rickard, Claire M ^a,b,c,i  

^a GRIFFITH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Administration, intravenous; Catheterization, peripheral; Catheters, indwelling; Infusion, intravenous; Nurse; Phlebitis; Thrombophlebitis; Vascular access device

Indexed keywords

EID: 85117598580     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2021.104095     Document Type: Article

References (73)

1. Abolfotouh, M.A., et al. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Ther. Clin. Risk Manag. 10 (2014), 993–1001.
2. Alexandrou, E., et al. The use of midline catheters in the adult acute care setting–clinical implications and recommendations for practice. J. Ass. Vascular Access 16:1 (2011), 35–41.
3. Alexandrou, E., et al. Extended dwell peripheral catheters in patients with difficult venous access: comparison of a peripheral intravenous catheter and midline catheter. Vascular Access, 4(1), 2018.
4. Alexandrou, E., et al. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J. Hosp. Med. 13:5 (2018), E1–E7.
5. Ascoli, G., Deguzman, P., Rowlands, A., Peripheral intravenous catheter complication rates between those indwelling>96 h to those indwelling 72–96 h: a retrospective correlational study. Int. J. Nurs. 1:2 (2012), 7–12.
6. Bahl, A., et al. Ultralong Versus Standard Long Peripheral Intravenous Catheters: a Randomized Controlled Trial of Ultrasonographically Guided Catheter Survival. Ann. Emerg. Med. 76:2 (2020), 134–142.
7. Ben Abdelaziz, R., et al. Peripheral venous catheter complications in children: predisposing factors in a multicenter prospective cohort study. BMC Pediatr., 17(1), 2017, 208.
8. Bolton, D., Improving peripheral cannulation practice at an NHS Trust. Br. J. Nurs., 19(21), 2010, 1346 1348-50.
9. Bruniera, F., et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur. Rev. Med. Pharmacol. Sci. 19:4 (2015), 694–700.
10. Budtz-Jorgensen, E., et al. Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure. Ann. Epidemiol. 17:1 (2007), 27–35.
11. Burridge, N., K, S., Australian Injectable Drugs Handbook (AIDH). 7th Ed., 2017, Society of Hospital Pharmacists of Australia, Collingwood, Victoria.
12. Carr, P.J., et al. A pilot intravenous cannulation team: an Irish perspective. Br. J. Nurs. 19:10 (2010), S19–S27.
13. Carr, P.J., et al. Vascular access specialist teams for device insertion and prevention of failure. Cochrane Database Syst. Rev., 3, 2018, CD011429.
14. Chen, S., O'Malley, M., Chopra, V., How common are indwelling devices in hospitalized adults? A contemporary point prevalence study in a tertiary care hospital. Am. J. Infect. Control, 2020.
15. Chico-Padron, R.M., et al. Comparative safety and costs of transparent versus gauze wound dressings in intravenous catheterization. J. Nurs. Care Qual. 26:4 (2011), 371–376.
16. Chopra, V., et al. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am. J. Med. 125:8 (2012), 733–741.
17. Chopra, V., et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect. Control Hosp. Epidemiol. 34:9 (2013), 908–918.
18. Cicolini, G., et al. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J. Adv. Nurs. 65:6 (2009), 1268–1273.
19. Cooke, M., et al. Not" just" an intravenous line: consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries. PLoS ONE, 13(2), 2018.
20. da Silva, G.A., Priebe, S., Dias, F.N., Benefits of establishing an intravenous team and the standardization of peripheral intravenous catheters. J. Infusion Nurs. 33:3 (2010), 156–160.
21. Dillon, M.F., et al. Factors that affect longevity of intravenous cannulas: a prospective study. Quarterly J. Med. 101:9 (2008), 731–735.
22. do Rego Furtado, L.C., Maintenance of peripheral venous access and its impact on the development of phlebitis: a survey of 186 catheters in a general surgery department in Portugal. J. Infusion Nurs. 34:6 (2011), 382–390.
23. Enes, S.M., et al. Phlebitis associated with peripheral intravenous catheters in adults admitted to hospital in the Western Brazilian Amazon. Rev. Esc. Enferm. USP 50:2 (2016), 263–271.
24. Fields, J.M., et al. The effect of vessel depth, diameter, and location on ultrasound-guided peripheral intravenous catheter longevity. Am. J. Emerg. Med. 30:7 (2012), 1134–1140.
25. Fitzpatrick, T.B., The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 124:6 (1988), 869–871.
26. Fox-Rawlings, S.R., et al. Diversity in medical device clinical trials: do we know what works for which patients?. Milbank Q. 96:3 (2018), 499–529.
27. Gorski, L.A., et al. Infusion therapy standards of practice. J. Infus. Nurs. 44:1S Suppl 1 (2021), S1–S224.
28. Gorski, L.A., Hagle, M.E., Bierman, S., Intermittently delivered IV medication and pH: reevaluating the evidence. J. Infus. Nurs. 38:1 (2015), 27–46.
29. Hadaway, L., Infiltration and extravasation. Am. J. Nurs. 107:8 (2007), 64–72.
30. Hawes, M.L., A proactive approach to combating venous depletion in the hospital setting. J. Infusion Nurs. 30:1 (2007), 33–44.
31. Helm, R.E., et al. Accepted but unacceptable: peripheral IV catheter failure. J. Infusion Nurs. 38:3 (2015), 189–203.
32. Hirschmann, H., et al. The influence of hand hygiene prior to insertion of peripheral venous catheters on the frequency of complications. J. Hosp. Infect. 49:3 (2001), 199–203.
33. Indarwati, F., et al. Incidence of peripheral intravenous catheter failure and complications in paediatric patients: systematic review and meta analysis. Int. J. Nurs. Stud., 102, 2020, 103488.
34. Keogh, S., et al. Varied flushing frequency and volume to prevent peripheral intravenous catheter failure: a pilot, factorial randomised controlled trial in adult medical-surgical hospital patients. Trials, 17(1), 2016, 348.
35. Keogh, S., et al. Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomised trial. BMC Med., 18(1), 2020, 252.
36. Kleidon, T.M., et al. Implementation of a paediatric peripheral intravenous catheter care bundle: a quality improvement initiative. J. Paediatr. Child Health 55:10 (2019), 1214–1223.
37. Kleidon, T.M., et al. Smile - Secure my intravenous line effectively: a pilot randomised controlled trial of peripheral intravenous catheter securement in paediatrics. J. Tissue Viability 29:2 (2020), 82–90.
38. Kleidon, T.M., et al. Flushing of peripheral intravenous catheters: a pilot, factorial, randomised controlled trial of high versus low frequency and volume in paediatrics. J. Paediatr. Child Health 56:1 (2020), 22–29.
39. Lanbeck, P., Odenholt, I., Paulsen, O., Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand. J. Infect. Dis. 34:7 (2002), 512–519.
40. Larsen, E., et al. Experiences of peripheral IV insertion in hospital: a qualitative study. British J. Nurs. 26:19 (2017), S18–S25.
41. Larsen, E., et al. Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study. Support. Care Cancer, 2020.
42. LaRue, G.D., Peterson, M., The impact of dilution on intravenous therapy. J. Infus. Nurs. 34:2 (2011), 117–123.
43. Lian, A., Rippey, J.C.R., Carr, P.J., Teaching medical students ultrasound-guided vascular access - which learning method is best?. J. Vasc. Access 18:3 (2017), 255–258.
44. Loveday, H.P., et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J. Hospital Infect. 86:Suppl 1 (2014), S1–70.
45. Marsh, N., et al. Securement methods for peripheral venous catheters to prevent failure: a randomised controlled pilot trial. J Vasc Access 16:3 (2015), 237–244.
46. Marsh, N., et al. Devices and dressings to secure peripheral venous catheters: a Cochrane systematic review and meta-analysis. Int. J. Nurs. Stud. 67 (2017), 12–19.
47. Marsh, N., et al. Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: a Multivariable Analysis of Peripheral Intravenous Catheter Failure. J. Hosp. Med. 13:2 (2018), 83–89.
48. Marsh, N., et al. Expert versus generalist inserters for peripheral intravenous catheter insertion: a pilot randomised controlled trial. Trials, 19(1), 2018, 564.
49. Marsh, N., et al. A novel integrated dressing to secure peripheral intravenous catheters in an adult acute hospital: a pilot randomised controlled trial. Trials, 19(1), 2018, 596.
50. Marsh, N., et al. The Benefit of a Vascular Access Specialist Placing a Peripheral Intravenous catheter: a Narrative Review of the Literature, 6, 2020, Vascular Access, 10–15.
51. Marsh, N., et al. Peripheral intravenous catheter non-infectious complications in adults: a systematic review and meta-analysis. J. Adv. Nurs., 2020.
52. McCallum, L., Higgins, D., Care of peripheral venous cannula sites. Nurs. Times, 108(34–35), 2012, 12 14-5.
53. Murayama, R., et al. Removal of peripheral intravenous catheters due to catheter failures among adult patients. J. Infusion Nurs. 40:4 (2017), 224–231.
54. O'Grady, N.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Am. J. Infect. Control 39:4 Suppl 1 (2011), S1–34.
55. Palefski, S.S., Stoddard, G.J., The infusion nurse and patient complication rates of peripheral-short catheters. A prospective evaluation. J. Intraven. Nurs. 24:2 (2001), 113–123.
56. Pandurangadu, A.V., et al. Ultrasound-guided intravenous catheter survival impacted by amount of catheter residing in the vein. Emerg. Med. J. 35:9 (2018), 550–555.
57. Patel, C.N., et al. The Effects of Missed Doses of Antibiotics on Hospitalized Patient Outcomes. J. Surg. Res. 233 (2019), 276–283.
58. Ray-Barruel, G., et al. Infusion phlebitis assessment measures: a systematic review. J. Eval. Clin. Pract. 20:2 (2014), 191–202.
59. Rickard, C.M., et al. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BioMed Central Med., 8, 2010, 53.
60. Rickard, C.M., et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet 380:9847 (2012), 1066–1074.
61. Rickard, C.M., et al. Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet 392:10145 (2018), 419–430.
62. Rickard, C.M., Ray-Barruel, G., Peripheral intravenous catheter assessment: beyond phlebitis. Lancet Haematol., 4:9 (2017), e402–e403.
63. Roszell, S., Jones, C., Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J. Infus. Nurs. 33:2 (2010), 112–118.
64. Royer, T.F., Improving short peripheral IV outcomes: a clinical trial of two securment methods. JAVA 8:4 (2003), 45–49.
65. Salgueiro-Oliveira, A., Veiga, P., Parreira, P., Incidence of phlebitis in patients with peripheral intravenous catheters: the influence of some risk factors. Australian J. Adv. Nursing, 30(2), 2012, 32.
66. Schelper, R., The aging venous system. J. Ass. Vascular Access 8:3 (2003), 8–10.
67. Singh, R., Bhandary, S., Pun, K.D., Peripheral intravenous catheter related phlebitis and its contributing factors among adult population at KU Teaching Hospital. Kathmandu Univ. Med. J. (KUMJ) 6:24 (2008), 443–447.
68. Tuffaha, H.W., et al. Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Appl. Health Econ. Health Policy 12:1 (2014), 51–58.
69. U.S. Department of Health and Human Services, F.a.D.A., Evaluation of sex-specific data in medical Devic clinical studies - guidance for industry and food and drug administration staff. Food and Drug Administration, 2014.
70. Wallis, M.C., et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect. Control Hosp. Epidemiol. 35:1 (2014), 63–68.
71. Webster, J., et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ, 337, 2008, a339.
72. Xu, L., et al. Heparinized saline versus normal saline for maintaining peripheral venous catheter patency in China: an open-label, randomized controlled study. J. Int. Med. Res. 45:2 (2017), 471–480.
73. Zingg, W., Pittet, D., Peripheral venous catheters: an under-evaluated problem. Int. J. Antimicrob. Agents 34:Suppl 4 (2009), S38–S42.